Palmitoylethanolamide in the Treatment of Failed Back Surgery Syndrome.

Antonella PaladiniGuistino VarassiGiuseppe BentivegnaSandro CarlettiAlba PiroliStefano Coaccioli

Published in: Pain research and treatment (2017)

This observational study provides evidence, albeit preliminary, for the efficacy and safety of um-PEA (Normast) as part of a multimodal therapeutic regimen in the treatment of pain-resistant patients suffering from failed back surgery syndrome.

Keyphrases

minimally invasive
end stage renal disease
coronary artery bypass
pain management
chronic kidney disease
ejection fraction
case report
prognostic factors
spinal cord injury
acute coronary syndrome